-174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

-174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race.

Mandal S, Abebe F, Chaudhary J. -174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race. Genet Mol Res. 2014 Jan 10; 13(1):139-51.

View in: PubMed

authors with profiles

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support